Funding for this research was provided by:
Foundation for the National Institutes of Health (CA115531 and EB02584, R35 CA22044901)
Welch Foundation (AT-584)
STEP-UP program (R25 DK113659)
Fulbright visiting scholarship (UID/QUI/00313/2019 and POCI-01-0145- FEDER-027996)
Howard Hughes Medical Institute
Received: 29 March 2021
Accepted: 25 August 2021
First Online: 6 November 2021
: All procedures involving human sample collection were carried out under a protocol approved by the institutional review board of the University of Texas Southwestern Medical Center.
: This manuscript is not concurrently submitted elsewhere, and all authors are aware of and fully agree with its contents.
: R.J.D. is the advisor for Agios Pharmaceuticals and Vida Ventures. The other authors declare no competing interests.